Edwards Lifesciences Corp (EW) Financial Statements (2026 and earlier)

Company Profile

Business Address ONE EDWARDS WAY
IRVINE, CA 92614
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,9761,6451,2151,4671,4031,517
Cash and cash equivalent3,0451,1447698631,1831,179
Short-term investments931501446604219338
Restricted cash and investments  31217 
Receivables727775643582515544
Inventory, net of allowances, customer advances and progress billings1,0871,168876727802641
Inventory1,0871,168876727802641
Prepaid expense121147110857559
Disposal group, including discontinued operation 27     
Other current assets348239196237208168
Other undisclosed current assets  5956817256
Total current assets:6,2854,0363,0963,1813,0912,984
Noncurrent Assets
Operating lease, right-of-use asset989492929480
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1,6861,7491,6331,5471,3951,060
Long-term investments and receivables3085841,2391,834802586
Long-term investments3085841,2391,834802586
Intangible asset, including goodwill, after accumulated amortization2,9531,6821,4501,4921,5051,504
Goodwill1,7771,2541,1641,1681,1731,168
Intangible asset, excluding goodwill, after accumulated amortization1,177428285324331337
Disposal group, including discontinued operation, noncurrent assets 11     
Deferred income tax assets992755484247231172
Other noncurrent assets722464299111120102
Total noncurrent assets:6,7705,3285,1975,3224,1463,504
TOTAL ASSETS:13,0559,3638,2938,5037,2376,488
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities973756625674562647
Taxes payable311953
Employee-related liabilities320237296
Accounts payable197201202205197180
Accrued liabilities776554424120110117
Debt      26
Derivative instruments and hedges, liabilities815214396
Restructuring reserve271216191517
Estimated litigation liability746953 3820
Disposal group, including discontinued operation 2     
Other undisclosed current liabilities421343307335241187
Total current liabilities:1,5051,1951,0221,032894902
Noncurrent Liabilities
Long-term debt and lease obligation598597596665668653
Long-term debt, excluding current maturities598597596596595594
Liabilities, other than long-term debt888771724780886548
Liability for uncertainty in income taxes385339268259214172
Estimated litigation liability 5394143191233 
Other liabilities358264218267252203
Operating lease, liability797370697359
Business combination, contingent consideration, liability 15 2662186173
Other undisclosed noncurrent liabilities 181143190  
Total noncurrent liabilities:1,4871,4481,4631,6341,5541,201
Total liabilities:2,9922,6442,4862,6672,4482,103
Equity
Equity, attributable to parent9,9986,6505,8075,8364,5744,148
Common stock655651646642636218
Treasury stock, value(6,192)(5,025)(4,144)(2,417)(1,904)(1,279)
Additional paid in capital2,6132,2741,9691,7001,4381,623
Accumulated other comprehensive loss(245)(243)(255)(158)(161)(156)
Retained earnings13,1678,9927,5906,0684,5653,742
Equity, attributable to noncontrolling interest 6569    
Total equity:10,0636,7195,8075,8364,5744,148
Other undisclosed liabilities and equity     215237
TOTAL LIABILITIES AND EQUITY:13,0559,3638,2938,5037,2376,488

Income Statement (P&L) ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues5,4406,0055,3825,2334,3864,348
Cost of revenue
(Cost of Product and Service Sold)
(1,118)(1,380)(1,080)(1,249)(1,081)(1,114)
Gross profit:4,3224,6254,3023,9843,3063,234
Operating expenses(2,944)(2,896)(2,529)(2,417)(2,395)(2,028)
Other operating income (expense), net0(17)(61)  (65)
Other nonrecurring (income) expense  (17)(61)  (65)
Other undisclosed operating income (loss) (177)36124(14)6
Operating income:1,3791,5341,7491,6908981,147
Nonoperating income1948238303540
Investment income, nonoperating1266736172332
Other nonoperating income6914313128
Interest and debt expense(20)(18)(19)(18)(16)(21)
Income from continuing operations before equity method investments, income taxes:1,5531,5981,7671,7029171,167
Other undisclosed loss from continuing operations before income taxes(5)     
Income from continuing operations before income taxes:1,5481,5981,7671,7029171,167
Income tax expense(152)(199)(246)(199)(93)(120)
Income from continuing operations:1,3961,3991,5221,5038231,047
Income before gain (loss) on sale of properties:1,5038231,047
Income from discontinued operations2,774     
Net income:4,1701,3991,5221,5038231,047
Net income attributable to noncontrolling interest53    
Net income available to common stockholders, diluted:4,1751,4021,5221,5038231,047

Comprehensive Income ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income:4,1701,3991,5221,5038231,047
Other comprehensive income (loss)(2)12    
Comprehensive income:4,1681,4121,5221,5038231,047
Comprehensive income, net of tax, attributable to noncontrolling interest53    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (97)3(5)(18)
Comprehensive income, net of tax, attributable to parent:4,1731,4151,4251,5078181,029

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: